সুইজারল্যান্ড -
ইতালীয় -
Swissmedic (Swiss Agency for Therapeutic Products)
insadol compresse rivestite con film
future health pharma gmbh - maydis olei fractionis nonsaponificabilis extractum (zea mays l., embryo) - compresse rivestite con film - maydis olei fractionis nonsaponificabilis extractum (zea mays l., embryo) 35.0 mg, auszugsmittel ethylis acetas, cellulosum microcristallinum, lactosum monohydricum 122.0 mg, silica colloidalis anhydrica, povidonum k 30, carboxymethylamylum natricum a, magnesii stearas, hypromellosum, titanii dioxidum, ethylcellulosum, diethylis phthalas, poly(alcohol vinylicus), talcum, e 102 1.10 mg, e 110 0.17 mg, lecithinum, xanthani gummi, e 132, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, triethylis citras, natrii hydrogenocarbonas, silica colloidalis anhydrica, natrii laurilsulfas, carmellosum natricum, maltodextrinum, glucosum monohydricum 0.31 mg, natrii citras dihydricus, pro compresso obducto, corresp. natrium 0.181-0.265 mg. - traditionsgemäss bei erwachsenen zur unterstützenden behandlung bei leichten entzündungen und erkrankungen des zahnfleisches, falls eine geeignete zahnpflege und mundhygiene alleine nach zahnärztlicher beurteilung nicht ausreichend sind - phytoarzneimittel
সুইজারল্যান্ড -
ইতালীয় -
Swissmedic (Swiss Agency for Therapeutic Products)
bijuva 1 mg / 100 mg capsule molli
future health pharma gmbh - estradiolum, progesteronum - capsule molli - estradiolum 1.0 mg ut estradiolum hemihydricum, progesteronum 100.0 mg, glyceroli mono/dioctanoas/decanoas, macrogolglyceridorum laurates, kapselhülle: gelatina, gelatina hydrolysata, glycerolum, e 129, titanii dioxidum, triglycerida media, phosphatidylcholinum, drucktinte: propylenglycolum, titanii dioxidum, polyvinylis acetas phtalas, macrogolum, pro capsula. - postmenopausale hormonsubstitutionstherapie - synthetika
সুইজারল্যান্ড -
ইতালীয় -
Swissmedic (Swiss Agency for Therapeutic Products)
actonel 35 mg le compresse gastroresistenti di
future health pharma gmbh - risedronas - le compresse gastroresistenti di - natrii risedronas 35.0 mg corresp. risedronas 32.48 mg, cellulosum microcristallinum silicificatum, dinatrii edetas, carboxymethylamylum natricum a, acidum stearicum, magnesii stearas, Überzug: acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum, triethylis citras, talcum, e 172 (flavum), simeticonum, polysorbatum 80, pro compresso obducto corresp. natrium 16.64 mg. - behandlung der osteoporose bei postmenopausalen frauen mit erhöhtem frakturrisiko - synthetika
ইতালী -
ইতালীয় -
Ministero della Salute
future live kela ace integratore alimentare 120 capsule
future live srl -
ইতালী -
ইতালীয় -
Ministero della Salute
future live kela car integratore alimentare 120 capsule
future live srl -
ইতালী -
ইতালীয় -
Ministero della Salute
future live lithoren retard integratore alimentare 60 compresse
future live srl -
ইতালী -
ইতালীয় -
Ministero della Salute
future live 5alfaprost integratore alimentare 30 perle
future live srl -
ইতালী -
ইতালীয় -
Ministero della Salute
future live enzuryl cist integratore alimentare 24 capsule gastroresistenti
future live srl -
ইতালী -
ইতালীয় -
Ministero della Salute
future live fernapyd integratore alimentare 30 capsule
future live srl -
সুইজারল্যান্ড -
ইতালীয় -
Swissmedic (Swiss Agency for Therapeutic Products)
femoston 1/10 mg compresse
viatris pharma gmbh - estradiolum, dydrogesteronum - compresse - i) tablette weiss: estradiolum 1 mg ut estradiolum hemihydricum 1.03 mg, lactosum monohydricum 119.1 mg, hypromellosum, maydis amylum, silica colloidalis anhydrica, magnesii stearas, hypromellosum, macrogolum 400, e 171, pro compresso obducto. ii) tablette grau: estradiolum 1 mg ut estradiolum hemihydricum 1.03 mg, dydrogesteronum 10 mg, lactosum monohydricum 110.2 mg, hypromellosum, maydis amylum, silica colloidalis anhydrica, magnesii stearas, poly(alcohol vinylicus), macrogolum 3350, talcum, e 171, e 172 (nigrum), pro compresso obducto. - terapia ormonale sostitutiva dopo la menopausa - synthetika